Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2022-05-05 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份补充质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the supplementary pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the pledge period, and related information about the shareholder's cumulative pledged shares. The document is short (1618 characters) and focuses on share pledge details, which is a capital structure update. It is not a full financial report, earnings release, or management discussion. It is not a report publication announcement or certification. Therefore, it fits best under Capital/Financing Update (CAP).
2022-05-05 Chinese
关于董事股份减持计划时间届满及未来减持计划的预披露公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding the expiration of a director's share reduction plan and the disclosure of a future share reduction plan by a company director. It details the director's shareholding changes, reduction quantities, prices, and compliance with relevant securities laws and stock exchange rules. The content focuses on insider share transactions by a company director, including past and planned share sales. There is no financial report, earnings data, or management discussion. The document fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is 2872 characters, which is consistent with a detailed announcement but not a full financial report. Therefore, the correct classification is Director's Dealing (DIRS).
2022-05-05 Chinese
2022年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2022 年第一季度报告全文" which translates to "2022 First Quarter Report Full Text". It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the first quarter of 2022. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It also mentions that the report is unaudited, which is typical for interim or quarterly reports. The length of the document (13,929 characters) and the detailed financial content confirm it is the actual quarterly report, not just an announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2022-04-29 Chinese
2021年年度股东大会的法律意见书
Regulatory Filings
2022-04-12 Chinese
2021年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021 Annual General Meeting Resolution Announcement" for Huabang Life Health Co., Ltd. It details the resolutions passed at the 2021 Annual General Meeting (AGM) held on April 12, 2022, including voting results on various reports and proposals such as the Board report, Supervisory report, Financial report, Profit distribution plan, Annual report, and others. The document includes detailed voting outcomes and legal opinions on the meeting's validity. The content is focused on announcing the results of the shareholder votes at the AGM rather than the full reports themselves. The document length is 2845 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, the document fits the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA).
2022-04-12 Chinese
东海证券股份有限公司关于华邦生命健康股份有限公司所属山东凯盛新材料股份有限公司境内上市之持续督导意见
Regulatory Filings
2022-04-01 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.